Doximity (NYSE:DOCS) Stock Price Crosses Below Fifty Day Moving Average - Should You Sell?

Doximity logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Doximity shares fell below their 50-day moving average, reaching $29.42 and last trading at $29.637, down 3.4%.
  • Analyst views are mixed: eight rate the stock Buy, 14 Hold and three Sell, giving it a consensus Hold rating and a $30.59 average price target.
  • Doximity reported quarterly EPS of $0.36, beating the $0.19 estimate, while revenue rose 3.6% year over year to $174.54 million.
  • Five stocks to consider instead of Doximity.

Doximity, Inc. (NYSE:DOCS - Get Free Report) passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $30.23 and traded as low as $29.42. Doximity shares last traded at $29.6370, with a volume of 2,020,066 shares changing hands.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Needham & Company LLC restated a "buy" rating and set a $41.00 price target on shares of Doximity in a research report on Friday, November 6th. Raymond James Financial reissued an "outperform" rating and set a $38.00 target price on shares of Doximity in a research note on Friday, October 16th. Wells Fargo & Company cut Doximity from an "equal weight" rating to an "underweight" rating and set a $18.00 target price for the company. in a report on Monday, August 10th. Evercore set a $35.00 target price on Doximity in a report on Tuesday, September 29th. Finally, Piper Sandler reiterated an "overweight" rating and set a $47.00 price target (up from $42.00) on shares of Doximity in a research note on Friday, August 7th. Eight investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $30.59.

Get Our Latest Research Report on Doximity

Doximity Stock Down 3.4%

The stock has a market capitalization of $5.29 billion, a PE ratio of 41.16, a price-to-earnings-growth ratio of 32.84 and a beta of 1.29. The stock has a fifty day moving average of $30.23 and a 200-day moving average of $25.19.

Doximity (NYSE:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.17. The company had revenue of $174.54 million for the quarter. Doximity had a return on equity of 15.80% and a net margin of 21.12%. Doximity's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.45 EPS. Equities research analysts expect that Doximity, Inc. will post 0.72 EPS for the current year.

Insider Activity

In other Doximity news, Director Watkin Phoebe L. Yang sold 1,290 shares of the stock in a transaction that occurred on Wednesday, September 30th. The shares were sold at an average price of $26.71, for a total value of $34,455.90. Following the sale, the director directly owned 24,744 shares of the company's stock, valued at approximately $660,912.24. This represents a 4.96% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kira Wampler sold 2,000 shares of the firm's stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $32.89, for a total transaction of $65,780.00. Following the completion of the sale, the director owned 27,923 shares in the company, valued at $918,387.47. The trade was a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 25,224 shares of company stock worth $801,442 in the last ninety days. 31.80% of the stock is owned by insiders.

Institutional Trading of Doximity

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Doximity in the 3rd quarter valued at about $45,000. Versant Capital Management Inc boosted its holdings in Doximity by 1,176.9% in the third quarter. Versant Capital Management Inc now owns 1,826 shares of the company's stock valued at $52,000 after purchasing an additional 1,683 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in Doximity by 59.9% in the third quarter. Nisa Investment Advisors LLC now owns 1,855 shares of the company's stock valued at $53,000 after purchasing an additional 695 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Doximity by 79.8% in the third quarter. Bessemer Group Inc. now owns 1,910 shares of the company's stock valued at $54,000 after purchasing an additional 848 shares in the last quarter. Finally, Parallel Advisors LLC increased its stake in Doximity by 111.0% in the first quarter. Parallel Advisors LLC now owns 2,560 shares of the company's stock valued at $60,000 after purchasing an additional 1,347 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Company Profile

(Get Free Report)

Doximity, Inc. operates a digital platform designed for medical professionals, including physicians and other clinicians. Its services support professional networking, medical news and research discovery, career development, and communication among healthcare professionals. The company also offers clinical workflow tools, including Doximity Dialer, which enables clinicians to make calls and conduct video visits using a work number, as well as digital fax and document services. Doximity provides marketing and recruitment solutions to healthcare organizations and life sciences companies.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines